Clinical and Translational Oncology

, Volume 12, Issue 2, pp 81–91

Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies

  • Gerardo Gutiérrez-Gutiérrez
  • María Sereno
  • Ambrosio Miralles
  • Enrique Casado-Sáenz
  • Eduardo Gutiérrez-Rivas
Educational Series Molecular Targets in Oncology

DOI: 10.1007/S12094-010-0474-z

Cite this article as:
Gutiérrez-Gutiérrez, G., Sereno, M., Miralles, A. et al. Clin Transl Oncol (2010) 12: 81. doi:10.1007/S12094-010-0474-z

Abstract

Chemotherapy-induced peripheral neuropathy (CIN) is a common toxicity of anticancer treatment and its incidence is growing. It significantly affects quality of life and is a dose-limiting factor that interferes with treatment. Its diagnosis can be established in clinical terms but some complementary tests can help when the diagnosis is difficult. There is still no proven method to prevent it that has become a standard of care in spite of the huge amount of investigation carried out in recent years. There are promising strategies that could help reduce the burden of this complication. This review will suggest an approach to the diagnosis of these disorders and provide an update on new therapies.

Keywords

ChemotherapyNeuropathyPainCancerPolyneuropathyNeuroprotection

Copyright information

© Feseo 2010

Authors and Affiliations

  • Gerardo Gutiérrez-Gutiérrez
    • 1
  • María Sereno
    • 2
  • Ambrosio Miralles
    • 1
  • Enrique Casado-Sáenz
    • 2
  • Eduardo Gutiérrez-Rivas
    • 3
  1. 1.Neurology DepartmentInfanta Sofía HospitalSan Sebastián de los Reyes, MadridSpain
  2. 2.Medical Oncology DepartmentInfanta Sofía HospitalSan Sebastián de los Reyes, MadridSpain
  3. 3.Neuromuscular Unit Neurology DepartmentHospital Universitario 12 de OctubreMadridSpain